With no less than 5 new classes of oral diabetes medications being introduced in the last 10 years, many practitioners are finding it difficult to keep them straight-not to mention injectable medications and insulin. This program will bring you up to speed on current FDA-approved oral and injectable diabetes medications, as well as what’s on the horizon. Educational objectives include learning mechanism of action, side effects, and dosing of diabetes medications; identification of onset, peak, and duration of currently available insulin; and nutritional considerations when making medication choices for diabetes management.”
Join fellow WAND members in the support of our educational initiative focused on diabetes and welcome Brenda Kalchbrenner, RD, CD, CDE as we:
- Describe the mechanism of action, side effects, and dosing guidelines for oral and injectable medications used in the treatment of type 2 DM.
- Identify the onset, peak, and duration of currently available insulin classes.
- Discuss factors used when making medication choices for hyperglycemia management.
This webinar is free for WAND Members, but registration is required. This webinar is worth 1 CPE hour.
About the Presenter:
Brenda has worked as a Registered Dietitian for 25 years, specializing in diabetes management for 15 years. She is currently employed as Lead Dietitian at Ascension Wisconsin Hospital-Franklin providing outpatient diabetes education to both individuals and groups of patients, as well as serving as a facilitator with the National Diabetes Prevention Program. She has conducted several in-person and virtual seminars, including “Pre-Diabetes: What’s Your Risk?”, “Diabetes and Pre-Diabetes: What’s the Big Deal?” for businesses and schools in the Milwaukee area, as well as “Obesity Management in Type 2 Diabetes” at the American Diabetes Association Primary Care Conference.
Please contact the WAND office at email@example.com or 920-560-5619 if you have any questions.